Lishann Ingram

Pharmaceutical and Biomedical Sciences (PBS)
Graduate Student


American Society for Pharmacology and Experimental Therapeutics (ASPET)
American Society for Biochemistry and Molecular Biology (ASBMB)
American Association of Cancer Research (AACR)
American Association of Pharmaceutical Scientists (AAPS)

Research Interests

Phospholipids as indicators of drug-resistant prostate cancer

Selected Publications

S. Pati, L. Ingram M.K. Sun, J.J. Wagner, and B.S. Cummings. Localization and Expression of CTP:Phosphocholine Cytidylyltransferase in Rat Brain following Cocaine Exposure. Journal of Chemical Neuroanatomy. (2018 Oct 23)

Li Q, Ingram L, Kim S, Beharry Z, Cooper JA, Cai H. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression. Neoplasia. 2018;20(3):233-243.

Wu, M., Ingram, L., Tolosa, E. J., Vera, R. E., Li, Q., Kim, S., Ma, Y., Spyropoulos, D. D., Beharry, Z., J., Fernandez-Zapico, M. E. and Cai, H. (2016) Gli Transcription Factors Mediate The Oncogenic Transformation Of Prostate Basal Cells Induced By A Kras-Androgen Receptor Axis. Journal of Biological Chemistry (2016): jbc.M116.753129.

Lori A. Hill Neves, Lishann M. Ingram, and Melissa B. Davis. (2011) The Characterization of Cell Line CRL-2335 as a Basal- Like Breast Carcinoma Model, Breast Cancer: Basic and Clinical Research (5) 67-72.